OTCMKTS:HAVLF

HAVN Life Sciences (HAVLF) Stock Price, News & Analysis

$0.02
0.00 (0.00%)
(As of 05/17/2024 ET)
Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$0.15
Volume
2 shs
Average Volume
5,482 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HAVLF stock logo

About HAVN Life Sciences Stock (OTCMKTS:HAVLF)

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.

HAVLF Stock Price History

HAVLF Stock News Headlines

HAVN.CN - HAVN Life Sciences Inc.
HAVN Life Sciences Inc (HAVN)
HAVN Life Provides Corporate Update
HAVN Life Sciences Inc. (HAVLF)
IIROC Trading Halt - HAVN
IIROC Trade Resumption - HAVN
HAVN Life enters supply agreement with MPB Group
See More Headlines
Receive HAVLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HAVN Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:HAVLF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Tim Moore (Age 65)
    Interim CFO, CEO & Chairman
    Comp: $128.11k
  • Ms. Jenna Pozar
    Chief Operations Officer
  • Mr. Paul More
    Controller

HAVLF Stock Analysis - Frequently Asked Questions

How have HAVLF shares performed in 2024?

HAVN Life Sciences' stock was trading at $0.06 on January 1st, 2024. Since then, HAVLF shares have decreased by 60.7% and is now trading at $0.0236.
View the best growth stocks for 2024 here
.

Are investors shorting HAVN Life Sciences?

HAVN Life Sciences saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 500 shares, a decline of 44.4% from the April 15th total of 900 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 5.0 days.
View HAVN Life Sciences' Short Interest
.

When did HAVN Life Sciences' stock split?

HAVN Life Sciences shares reverse split on the morning of Wednesday, August 3rd 2022. The 1-30 reverse split was announced on Wednesday, August 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of HAVN Life Sciences?

Shares of HAVLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:HAVLF) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners